Tesamorelin

Tesamorelin

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue, a 44-amino-acid peptide carrying a trans-3-hexenoyl group at the N-terminus. That modification improves its stability relative to native GHRH, which is why it is widely used as a research tool in studies of hypothalamic-pituitary signaling and the growth hormone axis.

In laboratory and preclinical research, Tesamorelin has been investigated for its potential effects on:

• GHRH receptor binding and signaling
• Somatotroph cell function
• Pulsatile growth hormone release
• GH / IGF-1 axis regulation
• Hypothalamic-pituitary feedback mechanisms
• Lipolysis and adipose tissue biology
• Visceral adipose tissue models
• Lipid metabolism pathways
• Hepatic lipid handling
• Glucose metabolism models
• Protein synthesis pathways
• Skeletal muscle physiology
• Peptide pharmacokinetics and enzymatic stability
• Receptor selectivity and binding affinity
• Endocrine signaling cascades

Tesamorelin remains an important research compound for investigating endocrine regulation, receptor-mediated peptide signaling, and metabolic pathways involving the growth hormone axis. Ongoing research continues to evaluate its pharmacological properties and biological mechanisms across multiple experimental models.

Research Use Only (RUO): This product is intended exclusively for laboratory and scientific research. It is not intended for human or veterinary use, diagnosis, treatment, or consumption.